ACTIVE

NOVADIP BIOSCIENCES

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-13,1 M €-398,7 %over 1 year

Gross margin1,6 M €-26,2 %over 1 year

Equity50 M €-24,9 %over 1 year

Workforce39,3 ETP-13,8 %over 1 year

Identity

Source · BCE/KBO

NOVADIP BIOSCIENCES is a Public limited company incorporated in 2013. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Mont-Saint-Guibert. It employs on average 39,3 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0535.575.602
Incorporation: 31/05/2013
Legal form: Public limited company
Registered office: Rue Granbonpré 11
1435 Mont-Saint-Guibert · WallonieSee on map
Contributed capital: 66 325 354,88 €
Latest accounts: 31/12/2025
Average workforce: 39,3 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology

Joint committees (2)

207
2070

Signals

Solid equityPositive cashflowHealthy social debts

Financials

Source · NBB, 15 filings

Trend over 13 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	1,6 M €	-26.2%	2,2 M €		–		–		2,5 M €
EBITDA	-2 M €	+22.0%	-2,5 M €	-19.2%	-2,1 M €	-14.8%	-1,8 M €	-132%	-789,3 k €
Operating result	-19,5 M €	-607%	-2,8 M €	-12.8%	-2,5 M €	-7.8%	-2,3 M €	-97.6%	-1,2 M €
Net result	-13,1 M €	-399%	-2,6 M €	-35.5%	-1,9 M €	+15.8%	-2,3 M €	-65.7%	-1,4 M €
Balance sheet
Equity	50 M €	-24.9%	66,6 M €	+0.6%	66,2 M €	+1.7%	65,1 M €	+25.7%	51,8 M €
Total assets	85,3 M €	-6.9%	91,5 M €	+14.1%	80,3 M €	+10.4%	72,7 M €	+18.4%	61,4 M €
Cash	877,9 k €	+141%	364,7 k €	-45.2%	665,7 k €	-79.9%	3,3 M €	-67.9%	10,3 M €
Debts	34 M €	+37.6%	24,7 M €	+76.1%	14 M €	+85.9%	7,5 M €	-21.6%	9,6 M €
Other
Workforce	39,3 ETP	-13.8%	45,6 ETP	+15.4%	39,5 ETP	+4.5%	37,8 ETP	-3.8%	39,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 9 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Drew Trivisonno	Director21/11/2024 → 11/05/2027
Patrick Van Beneden	Director16/11/2023 → 11/05/2027
AXXIS V EN C0464.259.123Represented by Gil Beyen	Director20/12/2018 → 11/05/2027
Eric Pâques	Director14/05/2019 → 11/05/2027
Jean-Pierre Bizet	Director30/07/2015 → 11/05/2027
SPARAXIS0452.116.307Represented by Christine Franssen	Director30/07/2015 → 11/07/2027
Theracell Consulting0535.788.408Represented by Denis DUFRANE	Managing director30/07/2015 → 11/05/2027Director30/07/2015 → 2017 accountsended
VIVES II - Louvain Technology Fund0838.819.178Represented by Philippe DURIEUX	Director10/05/2013 → 11/05/2027
Da Liu	Director

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
VIVES PARTNERS1004.227.835Represented by Philippe DURIEUX	Director12/02/2024 → 2024 accounts
Philippe Monteyne	Director20/10/2021 → 2022 accounts
SOPARTEC0402.978.679Represented by Philippe Durieux	Director20/10/2021 → 2023 accounts

Other companies at this address

Rue Granbonpré 11 1435 Mont-Saint-Guibert

Company	CBE no.
Ascend Performance Materials● Active	0810.113.316
Ascend Performance Materials Belgium Holdco● Active	1012.379.397
AUDANE INVEST● Active	0816.921.429
BiocSol● Active	1003.683.546
CEDRIC CLAERHOUDT● Active	0477.799.927
Cellaïon● Liquidation	0764.522.425
Clinigen Clinical Supplies Management● Active	0859.906.087
Cronos Sud● Active	1014.190.824
DE SMET AGRO● Active	0402.951.757
DE SMET S.A. - ENGINEERS & CONTRACTORS● Active	0438.987.752
FLEXSO BRUSSELS● Active	0898.889.892
Keiro● Active	0681.490.821
PARLYM BELGIUM● Active	1028.144.372
PARSMET MANAGEMENT● Active	1025.167.858
PROMETHERA BIOSCIENCES● Bankrupt	0809.788.365
TFP IMMO● Active	1032.940.330
The Akkermansia Company● Active	0664.529.083
THE TORREFACTORY PROJECT● Active	0679.686.720
Tools4Patient● Active	0534.842.954
VAT Group Ascend● Active	1002.911.308

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Full model	Full model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/07/2026	10/07/2025	05/06/2024	08/06/2023	25/01/2023	27/05/2021
General meeting	30/06/2026	17/06/2025	14/05/2024	09/05/2023	10/05/2022	11/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 15 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	30/06/2026	14/07/2026	French	PDF
Abridged model	31/12/2024	17/06/2025	10/07/2025	French	PDF
Full model	31/12/2023	14/05/2024	05/06/2024	French	PDF
Full model	31/12/2022	09/05/2023	08/06/2023	French	PDF
Abridged modelCorrection	31/12/2021	10/05/2022	25/01/2023	French	PDF
Abridged modelCorrection	31/12/2021	10/05/2022	12/10/2022	French	PDF
Abridged model	31/12/2021	10/05/2022	16/05/2022	French	PDF
Abridged model	31/12/2020	11/05/2021	27/05/2021	French	PDF
Abridged model	31/12/2019	12/05/2020	02/06/2020	French	PDF
Abridged model	31/12/2018	14/05/2019	05/06/2019	French	PDF
Abridged model	31/12/2017	08/05/2018	08/06/2018	French	PDF
Abridged model	31/12/2016	09/05/2017	24/05/2017	French	PDF
Abridged model	31/12/2015	10/05/2016	12/05/2016	French	PDF
Abridged model	31/12/2014	11/06/2015	11/06/2015	French	PDF
Abridged model	31/12/2013	14/05/2014	25/08/2014	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 9 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Drew Trivisonno	Director21/11/2024 → 11/05/2027
Patrick Van Beneden	Director16/11/2023 → 11/05/2027
AXXIS V EN C0464.259.123Represented by Gil Beyen	Director20/12/2018 → 11/05/2027
Eric Pâques	Director14/05/2019 → 11/05/2027
Jean-Pierre Bizet	Director30/07/2015 → 11/05/2027
SPARAXIS0452.116.307Represented by Christine Franssen	Director30/07/2015 → 11/07/2027
Theracell Consulting0535.788.408Represented by Denis DUFRANE	Managing director30/07/2015 → 11/05/2027Director30/07/2015 → 2017 accountsended
VIVES II - Louvain Technology Fund0838.819.178Represented by Philippe DURIEUX	Director10/05/2013 → 11/05/2027
Da Liu	Director

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
VIVES PARTNERS1004.227.835Represented by Philippe DURIEUX	Director12/02/2024 → 2024 accounts
Philippe Monteyne	Director20/10/2021 → 2022 accounts
SOPARTEC0402.978.679Represented by Philippe Durieux	Director20/10/2021 → 2023 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates07/09/2026
Démission et nomination d'un administrateur, du commissaire et
PDF
Mandates06/05/2026
DEMISSIONS, NOMINATIONS
PDF
Other09/01/2024
DIVERS
PDF
Capital / shares04/08/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Mandates28/11/2022
DEMISSIONS, NOMINATIONS
PDF
Capital / shares10/10/2022
CAPITAL, ACTIONS
PDF
Capital / shares24/05/2022
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Capital / shares23/02/2022
CAPITAL, ACTIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings13 filings

Mandates

Drew Trivisonno

Patrick Van Beneden

SPARAXIS

AXXIS V EN C

Theracell Consulting

VIVES II - Louvain Technology Fund

Jean-Pierre Bizet

Eric Pâques

Da Liu

VIVES PARTNERS

SOPARTEC

Yi Zhou

Show the 6 other mandates

201320142015201620172018201920202021202220232024202520262027

NOVADIP BIOSCIENCES

Rue Granbonpré 11, 1435 Mont-Saint-Guibert

Director

Managing directorDirector

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Granbonpré 11, 1435 Mont-Saint-GuibertCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00302283

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
NOVADIP BIOSCIENCESCurrent	accounts 2013 → 2025	Accounts 2025 · 2026-00302283

Events

2025
Annual accounts 2025-13,1 M €↓
15/09/2025
nominationNovel Ventures Limited · administrateur
17/06/2025
reconductionDeloitte Réviseurs d’Entreprises SRL · commissaire
2024
Annual accounts 2024-2,6 M €↓
21/11/2024
nominationDrew Trivisonno · administrateur
14/05/2024
nominationPatrick Van Beneden · administrateur
12/02/2024
nominationVIVES Partners SRL · administrateur
2023
Annual accounts 2023-1,9 M €↑
28/07/2023
augmentation_capital
2022
Annual accounts 2022-2,3 M €↓
29/09/2022
augmentation_capital
10/05/2022
nominationJulie Delforge · commissaire
10/05/2022
augmentation_capital
2021
Annual accounts 2021-1,4 M €↓
20/10/2021
nominationYi Zhou · administrateur
20/10/2021
reconductionJean Pierre Bizet · administrateur
20/10/2021
reconductionPhilippe Monteyne · administrateur
20/10/2021
reconductionSPARAXIS · administrateur
20/10/2021
reconductionSOPARTEC · administrateur
20/10/2021
reconductionEric Pâques · administrateur indépendant
20/10/2021
reconductionAxxis V&C · administrateur
20/10/2021
reconductionTheracell Consulting · administrateur
2020
Annual accounts 2020-1,3 M €↑
2019
Annual accounts 2019-2,3 M €↓
2018
Annual accounts 2018-1,9 M €↓
2017
Annual accounts 2017-1,2 M €↓
2016
Annual accounts 2016-1,2 M €↓
2015
Annual accounts 2015-973,3 k €↓
2014
Annual accounts 2014-26,7 k €↑
2013
Annual accounts 2013-155,8 k €
31/05/2013
IncorporationPublic limited company

NOVADIP BIOSCIENCES

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events